NCT05138159 2021-11-30
A Study of Donafenib Plus S-1 in Treating Patients With Metastatic Pancreatic Cancer After Chemotherapy With Nab-paclitaxel Plus Gemcitabine Regimen
Fudan University
Phase 2 Unknown
Clinical Trials
11 trialsNCT04808687 2021-03-22
Neoadjuvant Nab-Paclitaxel and S-1 in Resectable Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT03986294 2021-01-15
NAPAN
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 2 Unknown
NCT04377048 2020-05-06
Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer
National Taiwan University Hospital
Phase 2 Unknown
NCT03825328 2019-01-31
A Trial of NS/GEMOX Chemotherapy in Patients With Untreated Pancreatic Cancer ( HZ-NS/GEMOX-PC )
Harbin Medical University
Phase 2 Unknown
NCT03636308 2018-08-17
ASAGPAC
Peking University
Phase 2 Unknown
NCT02734680 2017-04-11
IFCSLAPC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Unknown
NCT02945267 2016-10-26
Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer
Chinese PLA General Hospital
Phase 4 Unknown
NCT02634502 2015-12-18
Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver Metastasis
Fudan University
Phase 2 Unknown
NCT01074996 2014-01-16
APC-S1
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Phase 2 Unknown
NCT00197431 2006-03-22
Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer
Hamamatsu University
Phase 2 Unknown